ArticleTranslational vision science & technology2025
Personalizing the Transition From 24-2 to 10-2 Visual Field Testing Using ARREST - A Simulation Study.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical Effective Dynamic Range and the Measurement Floor of SITA-Faster Visual Field Tests.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026Article
- Volumetric Analysis of Perimetry Tests to Guide Central Testing: The Functional Vulnerability Zone.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The decision to switch between peripheral (24-2) and central (10-2) visual field testing in glaucoma currently rests with clinicians and requires a choice between either intensively sampling central vision or including testing of more peripheral locations (not both). We evaluate an automated approach to incorporate 10-2 locations into the 24-2, without increasing test time or reducing the ability to detect glaucomatous progression at the 24-2 locations. Methods: We applied our previously published ARREST approach, restricting added locations to a 10-2 pattern (A10). Using computer simulation, the sensitivity of A10 for detecting progression was compared to a ZEST procedure on the 24-2 pattern. Input fields were a synthetic series of 10 visits (6 monthly) of 126 eyes, derived from empirical longitudinal 24-2 data from people with glaucoma. Results: Forty-seven of the 126 progressing visual field series had locations added by A10. The procedures used a similar number of presentations (mean ± SD: A10, 220 ± 27; ZEST, 226 ± 29). Area under the curve (AUC) and survival time for detecting progressing series were similar between methods. A10 allowed visualization of the macular visual field with higher fidelity. Conclusions: The A10 approach allows automated incorporation of 10-2 locations into the 24-2 pattern that are customized to individuals without increasing test times. Translational Relevance: The A10 enables higher spatial sampling in individually relevant areas of the 10-2, without neglecting testing of the more peripheral visual field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.